Does price disclosure in pharmaceutical advertising result in price transparency? Evidence from a randomized experiment

BACKGROUND: Policies that mandate list price disclosure in direct-to-consumer pharmaceutical advertising (DTCPA) cite price transparency among the benefits. The expectation is that price transparency will lead to changes in consumer behavior that will ultimately lower healthcare costs. OBJECTIVE: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollin, Ilene L., Ball, Jennifer Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526226/
https://www.ncbi.nlm.nih.gov/pubmed/36193449
http://dx.doi.org/10.1016/j.rcsop.2022.100180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526226/
https://www.ncbi.nlm.nih.gov/pubmed/36193449
http://dx.doi.org/10.1016/j.rcsop.2022.100180

Ejemplares similares